日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial

日本糖尿病性黄斑水肿患者接受玻璃体内注射阿柏西普 8 mg 治疗:PHOTON 试验的 48 周亚组分析

Suzuma, Kiyoshi; Murata, Toshinori; Shimura, Masahiko; Yoshida, Shigeo; Kishino, Genichiro; Berliner, Alyson J; Chu, Karen W; Reed, Kimberly; Vitti, Robert; Cheng, Yenchieh; Voronca, Delia; Bhore, Rafia; Leal, Sergio; Morgan-Warren, Peter; Schulze, Andrea; Schmidt-Ott, Ursula; Kobayashi, Masato; Sakamoto, Taiji

Early experience with renal autotransplant for renal artery stenosis in a 6-year-old patient with neurofibromatosis type 1: a case report

一例患有1型神经纤维瘤病的6岁患者肾动脉狭窄行肾自体移植的早期经验:病例报告

Wala, Samantha J; Beebe, Morgan; Warren, Patrick; Kallash, Mahmoud; Nathan, Jaimie; Rasmussen, Sara

2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort

一项观察性研究对临床实践中接受玻璃体内注射阿柏西普 2 mg 治疗的 nAMD 患者进行积极治疗方案的 2 年结果:XTEND 研究英国队列

Bailey, Clare; Chandran, Manju; Gale, Richard; Narendran, Nirodhini; Talks, James; McGoey, Hellen; Keshk, Zinab; Morgan-Warren, Peter; Allmeier, Helmut; Machewitz, Tobias; Patel, Praveen J; Varma, Deepali

Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept

专家组就优化新生血管性年龄相关性黄斑变性患者对生物类似药反应欠佳时的治疗效果达成共识:阿柏西普的作用

Narendran, Nirodhini; Bailey, Clare; Downey, Louise; Gale, Richard; Kotagiri, Ajay; Pearce, Ian; Rennie, Christina A; Sivaprasad, Sobha; Talks, James; Morgan-Warren, Peter; Napier, Jackie; O'Neil, Carolyn; Seeborne, Timothy

Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022

2012年至2022年临床实践中,通过预充式注射器或小瓶注射玻璃体内注射阿柏西普后,眼内炎症的报告发生率

Schmidt-Ott, Ursula; Fitzpatrick, Scott; Hasanbasic, Zoran; Leal, Sergio; Morgan-Warren, Peter; Zhang, Xin; Johnson, Kristian T

Trends in licence approvals for ophthalmic medicines in the United Kingdom

英国眼科药物许可审批趋势

Morgan-Warren, Peter J; Morarji, Jiten B

Effects of siRNA-Mediated Knockdown of GSK3β on Retinal Ganglion Cell Survival and Neurite/Axon Growth.

siRNA介导的GSK3β敲低对视网膜神经节细胞存活和神经突/轴突生长的影响

Ahmed Zubair, Morgan-Warren Peter J, Berry Martin, Scott Robert A H, Logan Ann

Opacification of hydrophilic intraocular lenses after Descemet stripping automated endothelial keratoplasty

Descemet膜剥离自动内皮角膜移植术后亲水性人工晶状体混浊

Morgan-Warren, Peter J; Andreatta, Walter; Patel, Amit K

Bimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot study

比马前列素/噻吗洛尔固定复方制剂与拉坦前列素在初治且进展风险高的青光眼患者中的疗效比较:一项初步研究

Gutierrez-Diaz, Esperanza; Silva Cotta, Jose; Muñoz-Negrete, Francisco J; Gutierrez-Ortiz, Consuelo; Morgan-Warren, Robert J; Maltman, John

A prospective, multicenter, noninterventional study of Optive Plus(®) in the treatment of patients with dry eye: the prolipid study

一项前瞻性、多中心、非干预性研究,旨在评估 Optive Plus® 治疗干眼症患者的疗效:脂质研究

Kaercher, Thomas; Thelen, Ulrich; Brief, Gerrett; Morgan-Warren, Robert J; Leaback, Richard